Simian foamy virus infection in humans: prevalence and management
1Laboratory of Retrovirus Research, Division of Viral Products, Center for Biologics Evaluation & Research, US Food & Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, USA. arifa.khan@fda.hhs.gov
Abstract:
Simian foamy viruses (SFVs) are highly prevalent in all nonhuman primate species and can infect humans following occupational and non-occupational exposure to infected animals and their tissues, blood or body fluids. Virus transmission results in a stable, persistent infection that seems to be latent. SFV infections are thus far nonpathogenic, with no evidence of adverse clinical outcome in their natural nonhuman primate hosts or by experimental injection in animals and upon cross-species transmission in humans. Since the emergence of pathogenic viruses from nonpathogenic viruses upon cross-species infection is well-documented for several retroviruses, it is prudent to take necessary precautions to deter SFV infections in humans. These steps will help prevent the emergence of a novel pathogen and reduce the risk of transmission of another potential pathogenic human retrovirus.
More Related Videos
09:07Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
06:25Analysis of Simian Immunodeficiency Virus-specific CD8+ T-cells in Rhesus Macaques by Peptide-MHC-I Tetramer Staining
Published on: December 23, 2016
Related Concept Videos
Cytomegalovirus Disease
Cryptococcal Meningitis
Toxoplasmosis
Respiratory Syncytial Virus Disease
Smallpox
Rabies
